GLP-1-based therapies for the treatment of resistant hypertension in individuals with overweight or obesity: a review.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- GLP-1-based therapies for the treatment of resistant hypertension in individuals with overweight or obesity: a review.
- Published In:
- EClinicalMedicine, 75, 102789 (2024)
- Database ID:
- RPEP-08463
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08463APA
Jarade, Candace; Zolotarova, Tetiana; Moiz, Areesha; Eisenberg, Mark J. (2024). GLP-1-based therapies for the treatment of resistant hypertension in individuals with overweight or obesity: a review.. EClinicalMedicine, 75, 102789. https://doi.org/10.1016/j.eclinm.2024.102789
MLA
Jarade, Candace, et al. "GLP-1-based therapies for the treatment of resistant hypertension in individuals with overweight or obesity: a review.." EClinicalMedicine, 2024. https://doi.org/10.1016/j.eclinm.2024.102789
RethinkPeptides
RethinkPeptides Research Database. "GLP-1-based therapies for the treatment of resistant hyperte..." RPEP-08463. Retrieved from https://rethinkpeptides.com/research/jarade-2024-glp1based-therapies-for-the
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.